Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: CD as API

January 19, 2026 CD as API / Pharma applications

Sugammadex vs. Neostigmine Reversal After Thoracoscopic Thymectomy in Myasthenia Gravis

Rapid and complete reversal of residual neuromuscular blockade (rNMB) is essential for safe postoperative recovery in patients with myasthenia gravis

Continue reading

January 12, 2026 CD as API / CD derivatives / Drug delivery / Non-pharma applications / Pharma applications / Uncategorized

Special Issue of the 21st International Cyclodextrin Symposium

The papers from the Special Issue of the 21st International Cyclodextrin Symposium published in Carbohydrate Polymers are available (https://www.sciencedirect.com/special-issue/10BLTS8S758).  The

Continue reading

January 9, 2026 CD as API / Pharma applications

Hydroxypropyl-Beta-Cyclodextrin (HPBCD) inhibits SARS-CoV-2 replication by modulating intracellular lipid dynamics

A multi-year scientific collaboration between Brasilian and American scientists from Federal University at Rio de Janeiro, Brazil, Laboratory of Immunoregulation,

Continue reading

January 6, 2026 CD as API / CD derivatives / Pharma applications

Sulfonated, sulfated thioglycosides and multivalence in heparanase inhibition

Heparan sulfate (HS) analogs are synthetic oligo- and polysaccharides designed to mimic or enhance several biological properties of native HS.

Continue reading

January 5, 2026 CD as API / Pharma applications

2,6‑di‑O‑methyl‑3‑acetyl‑β‑cyclodextrin: a novel approach to reducde infectivity of SARS‑CoV‑2 and Japanese encephalitis virus

Among 19 CD derivatives studied, pretreatment of viral particles with DMA-β-CyD significantly reduced infectivity (by 2.25–2.67 log₁₀ units after 180

Continue reading

December 26, 2025 CD as API / Drug delivery / Pharma applications

Neuroprotective effects of statins and cyclodextrins: review and potential role in dementia treatment

Dementia is a progressive and irreversible deterioration in cognition that has a significant impact on the person’s activities of daily

Continue reading

December 23, 2025 CD as API / CD derivatives / Pharma applications

Multifunctional biomimetic nanocarriers for the treatment of atherosclerosis

Atherosclerosis (AS) has been considered a systemic disease characterized by the excessive generation of reactive oxygen species (ROS) and the

Continue reading

a rat is standing on top of a plastic container
December 18, 2025 CD as API / CD derivatives / Pharma applications

Selective removal of 7-ketocholesterol by a CD-dimer, a novel atherosclerosis therapeutic candidate

The removal of the toxic oxidized cholesterol, 7-ketocholesterol (7KC), from cells through the administration of therapeutics has the potential to

Continue reading

December 15, 2025 CD as API / CD derivatives / Pharma applications

Dual activity of low-molecular-weight polymeric β-cyclodextrins against tuberculosis

/The biological properties of pβCD of different molecular weights were studied. Strikingly, only the low-molecular-weight pβCD (LMW-pβCD) displayed antibacterial activity,

Continue reading

December 11, 2025 CD as API / Pharma applications

Biomimetic cyclodextrin enzyme models for modulation of P. aeruginosa quorum sensing and host immune response

Quorum sensing (QS) is the cell-to-cell communication on cell density, which is based on signal molecules,  N-acyl-homoserine lactones (AHLs) for

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 … 35 Next Posts»

Recent Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Alkali Metal Adduct Formation in Cyclic Ion Mobility-Mass Spectrometry of O-Methylated Cyclodextrin Isomers
  • Doxycycline release from cyclodextrin oligomer-containing collagen gels
  • Cyclodextrin-based polymer materials and their applications – A review covering a 20-year period

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (70)
  • CD as API (347)
  • CD derivatives (414)
  • Cosmetics and toilettry (52)
  • Diagnosis (12)
  • Drug delivery (797)
  • E-ducation (63)
  • Environmental (135)
  • Events (234)
  • Food (225)
  • Gene delivery (20)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (403)
  • Other industrial use (107)
  • Pharma applications (1,189)
  • Supramolecular systems (40)
  • Uncategorized (152)

Top Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Alkali Metal Adduct Formation in Cyclic Ion Mobility-Mass Spectrometry of O-Methylated Cyclodextrin Isomers
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Cyclodextrins for Chemosensing - Book
  • Call for Book Chapters: Cyclodextrin Systems for Green Hydrogen Production
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Cyclodextrin-based polymer materials and their applications - A review covering a 20-year period
  • GRAS status of CD derivatives
  • Doxycycline release from cyclodextrin oligomer-containing collagen gels
  • Methyl salicylate/methyl-β-cyclodextrin inclusion complex modulates plant defense against cold and heat stress

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...